Delivery Order SPE2DR25D7005-SPE2DR26F3FAP
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,828.56 to AmerisourceBergen Drug Corp for the supply of Imitrex 6 mg/0.5 ml pen injections on January 15, 2026, with completion scheduled for January 16, 2026. This firm fixed-price delivery order is being fulfilled from the supplier's place of performance in Conshohocken, Pennsylvania. The contract was awarded on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's broader pharmaceutical...
- AmerisourceBergen Drug Corp was awarded a $4,896.10 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors. This firm fixed-price contract, designated as a non-set-aside award, is scheduled for completion by July 29, 2025, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors valued at $2,410.63. This is a firm fixed price delivery order with an ultimate completion date of September 30, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency (DLA) awarded a $1,835.70 firm fixed-price delivery order to Amerisourcebergen Drug Corp on January 22, 2026, for the supply of Imitrex 4 mg/0.5 ml pen injectors. This non-competitive delivery order represents a single task order under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award carries an ultimate completion date of January 23, 2026, with...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 15, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injections with a ceiling value of $2,587.82. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open procurement. The order is scheduled for completion by July 16, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen). The contract is for the delivery of a pharmaceutical product, Imitrex 6 mg/0.5 mL pen injections, with a ceiling value of $2,773.68 and a completion date of April 17, 2024. The contract is a Firm Fixed Price Delivery Order, awarded without any set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $1,028.75 to AmerisourceBergen Drug Corp for Imitrex 6 mg/0.5 ml pen injectors on January 29, 2026, with an ultimate completion date of January 30, 2026. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. and serves as a critical pharmaceutical...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imitrex 6 mg/0.5 mL pen injectors with a firm fixed price ceiling value of $1,501.15 and completion date of July 31, 2025. This competitively awarded, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Imitrex 6 mg/0.5 ml pen injectors valued at $2,443.61. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award to the qualified vendor. The order is scheduled for ultimate completion on April 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $2,595.76 firm fixed price delivery order to AmerisourceBergen Drug Corp for Imitrex 4 mg/0.5 mL pen injections on July 24, 2025, with an ultimate completion date of July 25, 2025. This non-set-aside award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DR25D7005Indefinite Delivery Contract
- SPE2DR25D7005-SPE2DR26F3FAPDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency on January 29, 2026, for the supply of Imitrex 6 mg/0.5 mL pen injections with a ceiling value of $1,330.19. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 30, 2026, and will be performed at the awardee's corporate office in Conshohocken, Pennsylvania. This award was made through open competition with no set-aside designation. This delivery order is issued under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. This comprehensive IDC serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. As a critical pharmaceutical distributor in the federal medical supply chain, Cencora/Amerisourcebergen provides an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 1/28/26 |